Publication | Closed Access

The celecoxib derivative kinase inhibitor AR-12 (OSU-03012) inhibits Zika virus via down-regulation of the PI3K/Akt pathway and protects Zika virus-infected A129 mice: A host-targeting treatment strategy

ImmunologyHost-targeting Treatment StrategyCell DeathVirologyAntiviral Drug DevelopmentAntiviral ResponseZika VirusMedicineCell SignalingNovel TherapyPi3k/akt Pathway